published-canonicalconceptmaha-epistemic/1.0

Autophagosome abundance

Autophagosome abundance is represented as one reviewable unit in the Longevity and metabolism graph. Its source, locator, scope, uncertainty, and prohibited inference remain attached to the claim rather than being generalized across the domain.

Bounded definition

A source-bounded concept record for autophagosome abundance within longevity and metabolism.

What the cited work establishes

The guidelines distinguish static autophagosome measurements from dynamic flux and describe assay-specific interpretation limits.

Limited to Assay interpretation sections for LC3, SQSTM1/p62, lysosomal inhibition, and autophagic flux. in “Guidelines for the use and interpretation of assays for monitoring autophagy”; this candidate records the concept boundary and does not pool results from uncited systems or studies.

Claims: urn:maha:claim:longevity-metabolism-autophagosome-abundance

What remains a separate question

Autophagosome abundance does not by itself establish system-level performance, safety, manufacturability, scalability, economic advantage, clinical benefit, or deployment readiness.

No single marker establishes autophagy rate, organismal benefit, or a longevity outcome.

Connected domain graph

Typed dependencies preserve publication state.

Only independently canonical records receive public links and relation statements. Draft graph topology remains private.

mechanistic dependencycanonical

Autophagic flux

inbound connection · mechanism

Autophagic flux is positioned after Autophagosome abundance in this bounded dependency sequence; the edge is navigational and does not assert equivalence or causation beyond the cited source scope.

Claim ledger

Every proposition keeps its own evidence state.

theoretical-modelsingle-study

The cited source supports treating autophagosome abundance as a distinct concept within the stated longevity and metabolism scope.

Scope
Limited to Assay interpretation sections for LC3, SQSTM1/p62, lysosomal inhibition, and autophagic flux. in “Guidelines for the use and interpretation of assays for monitoring autophagy”; this candidate records the concept boundary and does not pool results from uncited systems or studies.
Boundary
Autophagosome abundance does not by itself establish system-level performance, safety, manufacturability, scalability, economic advantage, clinical benefit, or deployment readiness.
Uncertainty
No cross-source quantitative interval is asserted. Definitions, operating conditions, samples, instruments, and outcome measures must be checked against the exact cited locator during review.
Replication
Independent replication and cross-platform transfer have not been compiled for this candidate; the evidence maturity refers only to the bounded source contract.

Primary sources

Citation, locator, rights, and boundary travel together.

  1. Source 1 · Autophagy

    Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky, et al.

    Exact locator
    Assay interpretation sections for LC3, SQSTM1/p62, lysosomal inhibition, and autophagic flux.
    Establishes
    The guidelines distinguish static autophagosome measurements from dynamic flux and describe assay-specific interpretation limits.
    Boundary
    No single marker establishes autophagy rate, organismal benefit, or a longevity outcome.
    Rights basis
    citation with paraphrase · The candidate uses original boundary language and a short paraphrase linked to the cited source. No source passage, figure, or table is reproduced.